Literature DB >> 11095271

Proteomics: new perspectives, new biomedical opportunities.

R E Banks1, M J Dunn, D F Hochstrasser, J C Sanchez, W Blackstock, D J Pappin, P J Selby.   

Abstract

Proteomics-based approaches, which examine the expressed proteins of a tissue or cell type, complement the genome initiatives and are increasingly being used to address biomedical questions. Proteins are the main functional output, and the genetic code cannot always indicate which proteins are expressed, in what quantity, and in what form. For example, post-translational modifications of proteins, such as phosphorylation or glycosylation, are very important in determining protein function. Similarly, the effects of environmental factors or multigenic processes such as ageing or disease cannot be assessed simply by examination of the genome alone. This review describes the underlying technology and illustrates several areas of biomedical research, ranging from pathogenesis of neurological disorders to drug and vaccine design, in which potential clinical applications are being explored.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11095271     DOI: 10.1016/S0140-6736(00)03214-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  56 in total

Review 1.  Molecular approaches to contraceptive development.

Authors:  U Natraj
Journal:  J Biosci       Date:  2001-11       Impact factor: 1.826

2.  Proteomic approach for the elucidation of biological defects in autism.

Authors:  M A Junaid; R K Pullarkat
Journal:  J Autism Dev Disord       Date:  2001-12

3.  Exploration of novel motifs derived from mouse cDNA sequences.

Authors:  Hideya Kawaji; Christian Schönbach; Yo Matsuo; Jun Kawai; Yasushi Okazaki; Yoshihide Hayashizaki; Hideo Matsuda
Journal:  Genome Res       Date:  2002-03       Impact factor: 9.043

4.  Laser capture microdissection and two-dimensional polyacrylamide gel electrophoresis: evaluation of tissue preparation and sample limitations.

Authors:  Rachel A Craven; Nick Totty; Patricia Harnden; Peter J Selby; Rosamonde E Banks
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

Review 5.  Current perspectives in cancer proteomics.

Authors:  Miriam V Dwek; Sarah L Rawlings
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

6.  The conservation of redundancy in genetic systems: effects of sexual and asexual reproduction.

Authors:  J A Morris; R D Morris
Journal:  J Biosci       Date:  2003-12       Impact factor: 1.826

Review 7.  On the molecular basis of the receptor mosaic hypothesis of the engram.

Authors:  Luigi F Agnati; Sergi Ferré; Giuseppina Leo; Carme Lluis; Enric I Canela; Rafael Franco; Kjell Fuxe
Journal:  Cell Mol Neurobiol       Date:  2004-08       Impact factor: 5.046

8.  Accelerating drug discovery.

Authors:  Sandra Kraljevic; Peter J Stambrook; Kresimir Pavelic
Journal:  EMBO Rep       Date:  2004-09       Impact factor: 8.807

9.  The diagnostic performance of the Mass Restricted (MR) score in the identification of microbial invasion of the amniotic cavity or intra-amniotic inflammation is not superior to amniotic fluid interleukin-6.

Authors:  Roberto Romero; Nicholas Kadar; Jezid Miranda; Steven J Korzeniewski; Alyse G Schwartz; Piya Chaemsaithong; Wade Rogers; Eleazar Soto; Francesca Gotsch; Lami Yeo; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2013-12-16

Review 10.  A proteomic primer for the clinician.

Authors:  Yurong Guo; Zongming Fu; Jennifer E Van Eyk
Journal:  Proc Am Thorac Soc       Date:  2007-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.